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Background: Atherosclerosis of the carotid arteries is a pathophysiological process 
increasing the risk of stroke. Carotid endarterectomy (CEA) and carotid artery 
stenting (CAS) are two recognised procedures indicated by the National Institute of 
Clinical Excellence (NICE) guidelines aiming to reduce the risk of stroke. However, 
both are associated with periprocedural complications (defined as within 30 days), 
particularly stroke. This review aims to identify which treatment, CAS or CEA, has 
a lower risk of periprocedural stroke in patients with symptomatic or asymptomatic 
carotid artery stenosis.
Methods: NICE Evidence Search identified relevant UK guidelines. Search strategies 
combining free-text terms searched the Cochrane Database of Systematic Reviews, 
MEDLINE, PubMed, CINAHL, and EMBASE for systematic reviews post-2011, 
and RCTs from 2015 onwards. Studies were included if they contained a comparison 
of CEA vs CAS with regards to periprocedural risk of stroke, and if they contained 
novel studies not seen in the NICE guidance. English language and full-text limits 
were applied.
Results: Searches identified 202 articles. Two reviewers performed independent 
screening identifying 3 guidelines, 7 systematic reviews, and 1 randomised control 
trial eligible for inclusion. Guidelines currently advocate usage of both procedures, 
unlike Scottish Guidelines (SIGN) who only support CEA. Four appraised systematic 
reviews found a statistically significant increase in stroke probability with CAS 
(p<0.05). The remaining reviews and RCT did not show a significantly increased risk 
with CAS (p>0.05).
Discussion: This review’s findings suggest that CAS is associated with an increased 
risk of periprocedural stroke when compared to CEA. Current UK guidelines by 
NICE and SIGN may require revisiting and take into account the new evidence not 
included in the original guidelines. There is a need for ongoing research as stenting 
technology improves over time.
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7BACKGROUND
Atherosclerosis is the pathophysiological process of lipid and fibrous 
tissue deposition within the tunica intima of arteries, leading to 
plaque formation. These plaques cause luminal narrowing and 
may rupture, becoming a site for thrombus formation. (1) Plaque 
formation and subsequent rupture in the carotid arteries can 
form emboli that migrate to the cerebral vasculature, potentially 
causing occlusion leading to ischaemia. (2,3) Ischaemic stroke, 
caused by such an occlusion, is defined as a sudden onset of 
neurological symptoms lasting more than 24 hours. (4) This form 
of stroke accounts for 85% of all strokes; the remaining 15% are 
haemorrhagic. (5)
Stroke is a major cause of morbidity and mortality, responsible 
for over 40,000 deaths in 2015, making it the 4th largest cause of 
death that year. (5) Non-lethal strokes have numerous long-term 
consequences such as loss of movement, speech problems, and life-
changing impacts on the patient’s relatives, especially if long-term 
care is required following the incident. (6)
Carotid artery stenosis is responsible for approximately 20% of all 
strokes in the UK. (7) There is a recognised need to manage the 
disease process of carotid atherosclerosis, to prevent adverse events 
such as stroke. Conservative measures are crucial in targeting 
modifiable risk factors, particularly in an ageing population 
where atherosclerosis is of increasing incidence. (8) Table 1 
shows the modifiable and non-modifiable risk factors for carotid 
atherosclerosis.
Table 1 - Modifiable and non-modifiable risk factors for carotid 
atherosclerosis (8)
Modifiable Non-Modifiable
Smoking Age
Blood Cholesterol Family History
Hypertension Gender
Obesity Genetics
Immobility
Diabetes
Treatment of established carotid artery stenosis is divided into 
medical and surgical therapies. (9) Medical therapies aim to 
reduce the risk of clot formation through agents such as aspirin 
and clopidogrel. There are two major surgical options: carotid 
endarterectomy (CEA) and carotid artery stenting (CAS). CEA 
is an open procedure performed by vascular surgeons, whereby 
the carotid artery is opened, and the plaque physically removed. 
Stenting is a minimally invasive procedure performed by 
interventional radiologists who feed a catheter through a distant 
artery, for instance the femoral, and placing a mesh to maintain the 
patency of the carotid artery lumen. Currently, NICE guidelines 
acknowledge a lack of evidence to support early stenting. (10) 
However, it can be performed at the surgeon and patient’s 
discretion. (11,12) Indications for carotid surgery as mentioned in 
the NICE TIA and Stroke Guideline CG68 can be found in Table 
2. (10)
Table 2 - NICE CG68 Indications for operating (10)
1. Individuals who have a suspected TIA/non-disabling stroke 
should undergo a clinical assessment and relevant Radiology 
with surgery potentially to follow.
2. Recognised stable neurological symptoms with associated 
luminal narrowing of >50% according to the North 
American Symptomatic Carotid Endarterectomy Trial 
(NASCET) criteria or >70% according to the European 
Carotid Surgery Trialists' Collaborative Group (ECST) 
criteria.
3. Surgery within 2 weeks of TIA/Stroke symptoms.
RATIONALE
Interventional radiology has emerged as a field involving minimally 
invasive surgery associated with lower rates of periprocedural 
complications, quicker recovery times and smaller scars compared to 
open surgery. (13) Therefore, it is perhaps expected that CAS could 
be a safer procedure with fewer complications compared to CEA. 
Scoping searches identified stroke to be a complication associated 
with both interventions.
This review was performed to ascertain the relative safety of the 
two surgical procedures, focussing on periprocedural stroke as 
the measure of safety, as stroke is the major adverse event that the 
surgeries are aiming to prevent. Similarly, periprocedural outcomes 
give a more accurate reflection of the surgery itself than longer-term 
outcomes which are more likely to be confounded by other factors 
contributing to the patient’s health. 
Patients with symptomatic and asymptomatic carotid stenosis 
represent the population most likely to receive surgery, therefore 
representing the population of interest. Symptomatic is defined 
as patients who have suffered neurological symptoms due to 
stenosis and asymptomatic as patients picked up incidentally. 
All author definitions of stenosis were accepted as this review 
compared periprocedural outcomes, not successful treatment of 
the stenosis itself. The intervention was CAS; the newer method 
to treat stenosis. For the comparator, the current established 
method, endarterectomy, was chosen. With regards to outcome, 
periprocedural stroke (stroke within 30 days post-procedure) was 
selected as it is a known complication of both procedures and 
reflects operational safety.
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The Population Intervention Comparator Outcome (PICO) for this 
review is therefore:
• Population: Patients with symptomatic/asymptomatic carotid 
artery stenosis requiring surgical intervention
• Intervention: Carotid artery stenting 
• Comparator: Carotid endarterectomy
• Outcome: Periprocedural stroke (defined as stroke within 30 
days post-procedure)
• Review Question: Which treatment, CAS or CEA, 
has a lower risk of periprocedural stroke in patients with 
symptomatic or asymptomatic carotid artery stenosis?
METHODOLOGY
A literature review was designed following a pre-defined protocol 
outlined below:
1. Creation of a PICO question
2. Development of inclusion and exclusion criteria
3. Formation of a search strategy for the databases NICE 
Evidence Search, MEDLINE, EMBASE, CINAHL, 
Cochrane Database of Systematic Reviews, and PubMed
4. Article selection and appraisal
5. Discussion and conclusion of findings
Search Strategy
UK guidelines were identified using NICE Evidence Search. 
The electronic databases NICE Evidence Search, MEDLINE, 
EMBASE, CINAHL, Cochrane Database of Systematic Reviews, 
and PubMed were searched in parallel for eligible systematic 
reviews. All the aforementioned databases except NICE Evidence 
Search were used to identify RCTs. Search terms used for each 
database were similar, generally including “Carotid stenosis 
AND stent AND endarterectomy” (Table 3). Variations in search 
terms were due to differences in the terminology accepted by the 
individual databases. 
Article Selection and Management
Date limits were pre-specified for systematic reviews to identify 
reviews and RCTs not seen in guidelines. RCTs were limited to 
find novel trials not in any reviews or guidelines. English language 
and full-text limits were applied for all searches. Two authors 
performed independent title and abstract screening against pre-
defined inclusion and exclusion criteria. Disagreements were 
resolved through consensus agreement with a third reviewer. 
Included papers compared carotid endarterectomy and stenting 
to treat stenosis, with assessment of periprocedural stroke as an 
outcome. Excluded papers did not compare the procedures, did 
not feature periprocedural stroke as an outcome, or were reviews/
RCTs found in guidelines. EndNote x7 (Clarivate Analytics, USA) 
managed study records throughout the review process.
Data Extraction
Two authors performed extraction of results comparing the 
two procedures and their risk of stroke in the periprocedural 
period. Appraisal of guidelines used the Appraisal of Guidelines 
for Research and Evaluation (AGREE) II tool. (14) Two authors 
independently appraised the Systematic reviews and the RCT 
using the appropriate Critical Appraisal Skills Programme (CASP) 
checklists. (15)
Table 3 -  Search terms
Search Database Search Terms Limits applied
Guidelines NICE Evidence 
Search
Carotid stenosis AND stent 
AND endarterectomy
NICE Accredited 
Guidance
Systematic 
reviews
Cochrane Carotid stenosis AND 
Stents AND Carotid 
Endarterectomy AND 
Stroke
Systematic Reviews 
Year 2011 – current
MEDLINE Carotid stenosis 
AND Stents AND 
Endarterectomy, Carotid 
AND Stroke
Systematic Reviews 
Year 2011 – current 
English Language
CINAHL Carotid endarterectomy 
AND carotid stenting 
AND stroke AND 
periprocedural
Year 2011 – current 
Systematic review
PubMed Carotid stenosis 
AND Stents AND 
Endarterectomy, Carotid 
AND Stroke
Systematic Reviews 
Year 2011 – current 
English Language
EMBASE Carotid Artery Obstruction 
AND Stent AND carotid 
endarterectomy AND 
cerebrovascular accident
Systematic Reviews 
Year 2011 – current
9Figure 1 -  Adapted PRISMA flowchart showing review process 
(16)
Randomised 
Controlled 
Trials
MEDLINE Carotid stenosis 
AND Stents AND 
Endarterectomy, Carotid 
AND Strokee
Randomised 
Controlled Trials 
Year 2015 - current
EMBASE Carotid Artery Obstruction 
AND Stent AND carotid 
endarterectomy AND 
cerebrovascular accident
Randomised 
Controlled Trials    
Year 2015 - current
PubMed Carotid stenosis 
AND Stents AND 
Endarterectomy, Carotid 
AND Stroke
Randomised 
Controlled Trials    
Year 2015 - current
CINAHL Carotid endarterectomy 
AND carotid stenting 
AND stroke AND 
periprocedural
Randomised 
Controlled Trials    
Year 2015 - current
Cochrane Carotid stenosis AND 
Stents AND Carotid 
Endarterectomy AND 
Stroke
 Trials                  
2015 - current
Results
From 202 search results a total of eleven eligible papers were found. 
These included three guidelines, seven systematic reviews and one 
RCT (Figure 1).
All three guidelines concluded that there is inadequate evidence 
to assess the efficacy and safety of early CAS (Table 4). (11,12,17) 
CEA remains the first-line intervention for both scenarios. NICE 
recommends performing CAS only if a skilled clinician is available 
and in certain situations (e.g. for research purposes) after patients 
have consented and been made aware of endarterectomy as an 
alternative. (11,12) The results of the systematic reviews and RCT 
are shown in Table 5.
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Table 4 - Summary of guidelines
Guideline Date of 
publication
Evidence base Conclusion
Carotid artery 
stent placement 
for asymptomatic 
extracranial carotid 
stenosis (IPG388) 
(11)
Author: NICE
April 2011 however 
evidence overview 
was performed in 
2010
2 meta-analyses
2 randomised 
controlled trials
2 non-randomised 
controlled studies
3 case series
3 case reports
Stenting for 
asymptomatic 
stenosis can be 
performed by 
skilled clinicians 
under special 
arrangements, 
such as research, 
but CEA remains 
first line
Carotid artery 
stent placement 
for symptomatic 
extracranial carotid 
stenosis (IPG389) 
(12)
Author: NICE
April 2011 however 
evidence overview 
was performed in 
2010
2 meta-analyses
4 randomised 
controlled trials
2 non-randomised 
controlled studies
5 case series
4 case reports
CEA is first line. 
Evidence accepts 
usage of stenting if 
the specialist and 
patient choose.
Management of 
patients with stroke 
or TIA: assessment, 
investigation, 
immediate 
management 
and secondary 
prevention (17)
Author: SIGN
December 2008 1 systematic review Carotid angioplasty 
and stenting is not 
recommended 
without further 
evidence of its safety 
and efficacy above 
CEA.
Table 5 - Systematic review and RCT results (18-25)
Name of Study Study 
Design
Number of 
trials
Total 
number 
of patients
Main results (CAS vs 
CEA)
Bonati LH et al. 
(2012) (18)
Systematic 
review
16 RCTs 7,527 OR 1.81, 95% CI: 1.40 
to 2.34, P<0.00001 I2 
= 12%
Gahramenpour 
A et al. (2012) 
(19)
Systenatic 
review
14 RCTs
15 meta-
analyses
1 data registry
74,003 No meta-analysis 
performed.
Paraskevas KI et 
al. (2016) (20)
Systematic 
review
21 data 
registries
Over 1.5 
million 
procedures 
assessed
No meta-analysis 
performed.
Raman G et al. 
(2013) (21)
Systematic 
review
3 RCTs
7 NRCS
377,361 NRCS RR 1.74 (95% 
CI: 1.41-2.16)
Zhang L et al. 
(2015) (22)
Systematic 
review
12 RCTs
3 Prospective 
Controlled 
Studies
20 
Retrospective 
comparative 
studies
27,525 Studies in 2011-2015 
RR 1.50 (95% CI 
1.14-1.98 p=0.004)       
I2 = 0%
Studies in 2006-2010 
RR was 1.61 (95% CI 
1.35-1.91 p< 0.001)     
I2 = 45%
Studies in 2001-2005     
RR 1.01 (95% CI 0.64-
1.60 p=0.95) I2 = 10%
Ouyang Y et al. 
(2015) (23)
Systematic 
review
9 RCTs 6,984 RR=1.62 (95% CI: 
1.31–2.00, P<0.0001, 
I2 =37%)
Vincent S et al. 
(2015) (24)
Systematic 
review
8 RCTs 7,091 RR=1.49 (95% CI: 
1.11-2.01, P value not 
stated, I2=42.2%)
Rosenfield K et 
al. (2016) (25)
RCT 1 RCT 1,453 CAS 2.8% vs CEA 
1.4%, p=0.23)
DISCUSSION
This literature review identified 3 guidelines and 7 systematic 
reviews and 1 RCT comparing CEA vs CAS and the development 
of stroke in the periprocedural period. (11,12,17-25) All provided 
evidence to suggest CEA is associated with a lower risk of 
periprocedural stroke, some with statistical significance. (11,12,17-
25)
Guideline Appraisal
The three eligible guidelines identified were the NICE IPG388 
(asymptomatic stenosis) (12) and IPG389 (symptomatic stenosis) 
(13) along with SIGN 108. (17) NICE IPG388/389 were 
produced in 2011 and clearly state the PICO and the outcomes to 
be assessed. (11,12) Outcomes compared patients that had either 
procedure performed, categorised as ‘efficacy’ (stroke, mortality, 
and arterial patency) and ‘safety’ (mortality, stroke, myocardial 
infarction, and other). (11,12) Searches of MEDLINE, CINAHL, 
EMBASE, Cochrane Database and other specified databases were 
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performed. (11,12) Searches yielded eligible meta-analyses, RCTs, 
non-randomised controlled studies (NRCS), case series, and case 
reports. Due to heterogeneity, NICE did not perform a meta-
analysis. (11,12) No mention of inclusion or exclusion criteria was 
made, and whilst the search strategy for MEDLINE was shown, 
other databases strategies were not included. (11,12)
Results for the studies used were given as relative risks (RR) and 
hazard ratios (HR), and significance was defined as a p<0.05. Three 
of the studies in IPG388 (asymptomatic stenosis) (1 meta-analysis, 
1 RCT and 1 NRCS) showed that CEA had a significantly lower 
rate of periprocedural stroke. (11) IPG389 demonstrated a similar 
picture in symptomatic patients, with CAS significantly increasing 
periprocedural stroke in five (2 meta-analyses, 3 RCTS) of the 
17 studies, although most studies found no statistically significant 
difference. (12) Both guidelines acknowledged the use of ‘low 
quality’ evidence, concluding endarterectomy remains first-line, 
but this does not represent a contraindication for stenting to occur. 
(11,12)
SIGN Guideline 108 was produced in 2008 which recommends 
against using stenting to treat both symptomatic and asymptomatic 
stenosis. (17) The basis of this recommendation is entirely from the 
meta-analysis by Ederle et al. (26) This analysis is also appraised 
by NICE and it is interesting to note that the conclusion by SIGN 
differs to NICE despite both using the same meta-analysis. The 
SIGN guideline, however, lacked the methodological rigour of 
the NICE guidelines, with no defined search strategy and no 
explanation of how the evidence was sourced.
 
Systematic Reviews Appraisal
A total of seven systematic reviews were included (18-24); these 
vary in the study types featured, but all suggest CAS to be associated 
with increased risk of periprocedural stroke compared to CEA. 
(18-24) Three limited their reviews to only RCTs. (18, 23,24) 
Another three included RCTs along with other study designs such 
as meta-analyses and retrospective studies. (19,21,22) One review 
looked at dataset registries in isolation. (20) Due to variation in 
studies included, only five performed meta-analyses of the data 
that they collected. (18, 21-24) None of the systematic reviews 
looked solely at UK populations and were mainly North American 
in origin. Given the variation in international healthcare systems, 
there may be questionable applicability to UK populations. Those 
looking at only RCTs contained the smallest numbers of patients 
(ranging from 6988 to 7527 patients), while the study looking at 
dataset registries contained a pool of over 1.5 million procedures. 
Six out of seven reviews (except Raman et al.) (21) looked at both 
asymptomatic and symptomatic patients. 
Search strategy quality varied across the reviews, with the most 
comprehensive search strategy performed by Bonati et al. (18) They 
searched for RCTs in CENTRAL, MEDLINE, EMBASE, Science 
Citation Index, and Cochrane Stroke Group Trials Register. 
Additionally, they searched three registries for ongoing trials, 
searched reference lists for relevant studies, and contacted experts in 
the field. Only Bonati et al. (18) and Paraskevas et al. (20) had two 
independent reviewers perform a title screen of each database. Most 
of the reviews limited their inclusion criteria to English language 
only, with two exceptions: Vincent et al. (24) accepted English 
and French languages, while Bonati et al. (18) did not apply any 
language limits.
Additionally, Paraskevas et al. (20) was the only study to apply 
a date limit to their search by excluding pre-2008 studies. They 
justified this by wanting to exclude historical studies, however, 
no justification was made as to why 2008 was seen as a cut off. All 
reviews performed quality assessments of their studies and reviewed 
for bias, except for Gahramenpour et al. (19) Furthermore, only 
Bonati et al. supported each of their judgements of bias using quotes 
from the original trials. (18) Use of a consistent tool allows a reader 
to critique the authors’ bias assessments and ensure that the authors 
were not biased themselves. 
All but Gahramenpour et al. (19) or Paraskevas et al. (20) performed 
a meta-analysis of the data. Only Paraskevas et al. justified their 
lack of meta-analysis, stating that baseline patient characteristics 
and outcomes were reported variably, and there was substantial 
heterogeneity in the registries used. (20) The five meta-analyses 
measured heterogeneity using I2 statistics. The I2 values varied 
between 0 and 45% when analysing RCTs, indicating low to 
moderate heterogeneity as per Cochrane definitions. (27,28)
In reviews where RCTs were used, the most common RCTs 
were CREST, (29) EVA-3S, (30) SAPPHIRE, (31) SPACE, (32) 
and ICSS. (33) These were large-scale RCTs with the smallest 
including 334 patients (SAPPHIRE (31)) and the largest 2522 
(CREST (29)). These five in particular were all considered to 
have low bias when assessed by two independent reviewers in 
Bonati et al. (18) Three of the aforementioned RCTs used in the 
meta-analyses by Bonati et al. (20) and Zhang et al. (22) found a 
statistically significant difference in our primary outcome of stroke 
(EVA-3S, (30) ICSS, (33) CREST (29)) and 2 (SAPPHIRE (31) 
and SPACE (32)) did not, however, the cumulative data did point 
to a significant difference.
Bonati et al. presented their results as odds ratios, finding that in 
symptomatic patients, CAS had statistically significant increased 
odds of stroke (OR 1.81, 95% CI: 1.40 to 2.34, P<0.00001). (18) 
Four studies presented their findings in the form of relative risks 
(Vincent et al., Ouyang et al., Raman et al. and Zhang et al.). (21-
24) Their findings varied between RR=1.49 (95% CI: 1.11-2.01) 
(Vincent et al. (24)) and RR=1.74 (95% CI: 1.41–2.16) (Raman 
et al. (21)). A notable abnormality with Ouyang et al. (23) was the 
lack of correlation of results in the abstract and results sections of 
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the article. 
Interestingly, not all of the studies in Zhang et al. support this 
conclusion. (22) The authors performed a chronological analysis 
and found that studies from 2001-2005 showed no statistically 
significant difference between the procedures. (22) In their 
discussion, they attribute this to the novelty of the procedure at that 
time, thus CAS was only used in simple cases. (22) 
RCT Appraisal
The ACT-1 trial had a clearly focused PICO, with the aims 
being well defined. (25) The sample size was large, with 
1453 patients randomised at a ratio of 3:1 to receive CAS or 
CEA. Randomisation was performed with use of a web-based 
system. (25) Blinding was not possible due to the nature of the 
interventions; this increases the possibility of bias. A baseline 
characteristics table is included in the study and shows similar 
characteristics between the two study arms. Important possible 
confounders such as age, gender, cigarette smoking, diabetes and 
previous cardiovascular disease were considered. The presence of 
two similar groups indicates successful randomisation. Moreover, 
the study mentions that analysis was by intention to treat (ITT). 
This refers to analysis with respect to the groups to which 
participants were originally randomised. The inclusion criteria 
for ACT-1 was specific; it focused on patients aged 79 years or 
younger, with severe carotid stenosis who were asymptomatic and 
not considered to be at high risk of stroke. (25) This specificity may 
limit applicability to the wider population. 
Review Findings
This review identified literature suggesting CAS is associated 
with increased periprocedural stroke relative to CEA. Given 
Interventional Radiology and Endovascular Surgery are modern 
and rapidly advancing fields, it is possible that periprocedural 
outcomes will change over time as technology improves. Previous 
evidence has shown that improved operator skill is associated with 
superior outcomes (34-36) and that the use of different stenting 
technology has been associated with variations in safety outcomes. 
(37) Relevant RCTs were included, published after the most recent 
systematic review to see if contemporary evidence supports the 
trend seen up until now.
Currently, NICE guidelines withhold from offering any definitive 
recommendation regarding the use of CAS over CEA. (11,12) 
They appreciate that CAS is an expanding field and recommend 
the use of stenting for research purposes. On the other hand, SIGN 
concluded that stenting was not recommended without further 
evidence. The SIGN guidelines were published in 2008, before 
the results of many important large-scale trials were released. This 
guideline is in need of an update. (17)
As previously alluded to, our review seems to indicate that the 
NICE guidelines need updating regarding the safety of carotid 
stenting versus endarterectomy, however, this review focused on 
a single outcome. Many of the studies we analysed considered 
a number of important safety and efficacy outcomes, such as 
periprocedural myocardial infarction. In order to make a conclusive 
recommendation, a multitude of periprocedural complications 
should be looked at to gauge the overall picture of CAS vs CEA. 
Similarly, factors such as patient preference, specialist availability, 
and cost effectiveness play a role in national decision-making. 
Limitations
A limitation of our review was our exclusion of studies which we 
were unable to access in full or those which were non-English 
language. Where information was absent or unclear, a future review 
could contact study authors to obtain information.  Furthermore, 
we did not search for ongoing or unpublished trials, which could 
provide relevant up-to-date results reflecting current practice.
CONCLUSION
This review aimed to compare the safety of two procedures, 
endarterectomy and stenting, to ascertain which is associated with 
a greater risk of periprocedural stroke. The conclusion, based on 
available research, suggests stenting is associated with an increased 
risk of periprocedural stroke in asymptomatic and symptomatic 
patients when compared to carotid endarterectomy. This may 
change as surgical practice continues to evolve. Based on the 
probability of periprocedural stroke, endarterectomy may remain 
preferable to stenting, until adequate high-impact research can 
argue to the contrary.
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